KK
CLB icon

KLP Kapitalforvaltning’s Core Laboratories CLB Stock Holding History

KLP Kapitalforvaltning’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$117K Hold
10,000
– – ﹤0.01% 2049
2026
Q1 		$168K Hold
10,000
– – ﹤0.01% 1882
2025
Q4 		$160K Buy
10,000
+1,400
+16% +$20.8K ﹤0.01% 1915
2025
Q3 		$106K Hold
8,600
– – ﹤0.01% 2052
2025
Q2 		$99.1K Hold
8,600
– – ﹤0.01% 2042
2025
Q1 		$129K Hold
8,600
– – ﹤0.01% 1926
2024
Q4 		$149K Buy
+8,600
New +$166K ﹤0.01% 1940

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

KLP Kapitalforvaltning's CLB Position: Q2 2026 in Review

KLP Kapitalforvaltning held its Core Laboratories (CLB) position steady in Q2 2026 at 10,000 shares worth $117K. The position accounts for ﹤0.01% of the portfolio, ranked #2049.

KLP Kapitalforvaltning first reported a position in CLB in Q4 2024 and has held it in 7 quarters since. The position peaked at $168K in Q1 2026. 187 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

  • KLP Kapitalforvaltning held 10,000 shares of Core Laboratories worth $117K as of Q2 2026.
  • KLP Kapitalforvaltning left its Core Laboratories share count unchanged in Q2 2026.
  • Core Laboratories made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #2049 holding.
  • KLP Kapitalforvaltning first reported a position in Core Laboratories in Q4 2024 and has held it in 7 quarters since.
  • KLP Kapitalforvaltning's Core Laboratories position peaked at $168K in Q1 2026.
  • 187 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.